These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7940814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
    van Wezel HB, Hilbrands LB, Koene RA, Hoitsma AJ.
    Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A, Sells RA, Bakran A, Tewari A.
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation.
    Pedersen EB, Hansen HE, Kornerup HJ, Madsen S, Sørensen AW.
    Nephrol Dial Transplant; 1993 Aug; 8(3):250-4. PubMed ID: 8385294
    [Abstract] [Full Text] [Related]

  • 8. Long-term cyclosporine A treatment does not progressively impair renal graft function: a 5-year follow-up study.
    Linder R, Restifo AC, Lindholm A, Groth CG.
    Transplant Proc; 1991 Aug; 23(4):2210. PubMed ID: 1871848
    [No Abstract] [Full Text] [Related]

  • 9. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA, Sally S, Foda MA, Sobh MA, el-Sherif AK, Ghoneim MA.
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract] [Full Text] [Related]

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. First-line cyclosporin A monotherapy in cadaveric renal transplantation.
    Sells RA, Chandrasekhar P, Aikawa A, Morris A, Ward RG, Bakran A, Bone JM, Bell GM, Brown MW.
    Transplant Proc; 1994 Oct; 26(5):2499-500. PubMed ID: 7940766
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V, Jirasiritham S, Chiewsilp P.
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract] [Full Text] [Related]

  • 15. A prospective study on the influence of cyclosporine and azathioprine on renal allograft survival and function.
    Henny FC, Kootte AM, van Bockel JH, Baldwin WM, Hermans J, Bos B, van Es LA, Paul LC.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1853-5. PubMed ID: 3079050
    [No Abstract] [Full Text] [Related]

  • 16. A 1-year prospective randomized study in Korean living donor kidney transplant recipients: comparing cyclosporine monotherapy and cyclosporine/prednisolone during the maintenance phase of immunosuppression.
    Park K, Kim ST, Lee SR, Koh YB, Kim HC.
    Transplant Proc; 1994 Aug; 26(4):1985-6. PubMed ID: 8066642
    [No Abstract] [Full Text] [Related]

  • 17. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients.
    Ebel H, Lange H.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized controlled trial of complete steroid withdrawal in renal transplant patients receiving triple immunosuppression.
    Ratcliffe PJ, Firth JD, Higgins RM, Smith B, Gray DW, Morris PJ.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):590. PubMed ID: 8438427
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.